“…Gelbased processes and mass spectrometry (reviewed in [9][10][11]) as well as antibody microarrays were applied. Antibody microarrays have become a robust proteomic tool for highthroughput analyses toward a better understanding of disease biology, its early detection, discrimination of tumours and the monitoring of disease progression [12,13]. The platform also serves as a complementary system to other comprehensive proteomic approaches [14].…”